Pre-clinical Animal Models for OA

Clinician scientists studying osteoarthritis commonly endeavor to choose an animal model that most closely assimilates to human disease to best translate the therapy they are developing in the most efficient and cost-effective way. Correct choice of the preclinical model can mean the success or failure of the therapy as all-to-frequently the therapy fails due to inappropriate modelling of disease.
Understanding the broad questions and considerations clinician scientists should be asking is paramount to successfully developing and optimizing a treatment. Join us for a conversation on OA and preclinical modeling.
This workshop is brought to you by the ICRS Translational Research Committee and hosted by Prof. Laurie Goodrich, featuring a presentation by Prof. Cecilia Pascual-Garrido.